Table 2.
Subgroup analysis by region showing the prevalence of clinical, immunological and VF among children in Ethiopia, 2020.
| Subgroup analysis (by region) | Overall TF prevalence (95%CI) | CF prevalence (95%CI) | IF prevalence (95%CI) | VF prevalence (95%CI) |
|---|---|---|---|---|
| Addis Ababa | 18.10 (9.72, 26.47) | 5.90 (4.57, 7.23) | 8.90 (4.09, 13.71) | 1.89 (0.40, 3.38) |
| Amhara | 12.27 (6.78, 17.76) | 11.80 (7.70, 15.90) | 6.03 (2.42, 9.64) | 6.76 (4.49, 9.04) |
| Oromia | 15.07 (11.11, 19.03) | 8.86 (1.84, 15.87) | 8.17 (3.72, 12.62) | 10.95 (2.76, 19.13) |
| Tigray | 23.76 (19.61, 27.92) | 4.46 (2.44, 6.48) | 4.70 (2.64, 6.76) | 13.86 (10.49, 17.231 |
CF clinical failure, IF immunological failure, VF virologic failure, TF treatment failure.